Stephanie Reeder
Alzheimer's Association(US)Resonance Research (United States)(US)Banner Alzheimer’s Institute
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Functional Brain Connectivity Studies, Bioinformatics and Genomic Networks, Advanced Neuroimaging Techniques and Applications
Most-Cited Works
- → Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo(2006)164 cited
- → Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease(2021)96 cited
- → Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease(2017)55 cited
- → Amphetamine‐induced dopamine release: Duration of action as assessed with the D2/3 receptor agonist radiotracer (––)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) in an anesthetized nonhuman primate(2006)29 cited
- → Association between an Alzheimer’s Disease-Related Index and APOE ε4 Gene Dose(2013)14 cited
- → Using the Artificial Neural Network to discriminate between normal controls with different APOE e4 genotypes and probable AD cases in PIB-PET studies(2009)1 cited
- → Characterization of lacosamide pharmacokinetics in older adults with epilepsy (P4-1.007)(2023)
- → Pharmacological evaluation of the novel D2/3 agonist radiotracer [11C]-(+)-PHNO in anesthetized non-human primates: A potential D3 receptor preferring agonist?(2006)